Viewing Study NCT04211103


Ignite Creation Date: 2025-12-24 @ 7:32 PM
Ignite Modification Date: 2025-12-25 @ 5:14 PM
Study NCT ID: NCT04211103
Status: UNKNOWN
Last Update Posted: 2021-08-27
First Post: 2019-12-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pembrolizumab in Pre Neoplastic High Grade HPV-related Vulvar and Cervical Lesions
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-10-14
Start Date Type: ACTUAL
Primary Completion Date: 2024-09-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-09-01
Completion Date Type: ESTIMATED
First Submit Date: 2019-12-22
First Submit QC Date: None
Study First Post Date: 2019-12-26
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-08-24
Last Update Post Date: 2021-08-27
Last Update Post Date Type: ACTUAL